Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorKuzu, İdris
dc.contributor.authorZuhur, Sayid Shafi
dc.contributor.authorDemir, Nazan
dc.contributor.authorAktaş, Gökce
dc.contributor.authorÖztürk, Feyza Yener
dc.contributor.authorAltuntaş, Yüksel
dc.date.accessioned2022-05-11T14:39:55Z
dc.date.available2022-05-11T14:39:55Z
dc.date.issued2016
dc.identifier.issn0423-104X
dc.identifier.urihttps://doi.org/10.5603/EP.a2016.0028
dc.identifier.urihttps://hdl.handle.net/20.500.11776/8793
dc.description.abstractIntroduction: Late-night salivary cortisol is a frequently used and easily implemented diagnostically valuable test for the diagnosis of overt Cushing's syndrome. The use of late-night salivary cortisol in the diagnosis of subclinical Cushing's syndrome is somewhat controversial. In this study, we aimed to determine the diagnostic value of late-night salivary cortisol in diagnosing subclinical Cushing's syndrome and compare it with 24-hour urinary free cortisol levels (UFC). Material and methods: The study consisted of 33 cases of subclinical Cushing's syndrome, 59 cases of non-functioning adrenal adenoma, and 41 control subjects. Late-night salivary cortisol and UFC were measured in all the cases. The diagnosis of subclinical Cushing's syndrome was based on combined results of 1 mg dexamethasone suppression test > 1.8 mu g/dL and ACTH < 10 pg/mL. Results: Mean late-night salivary cortisol levels in subjects with subclinical Cushing's syndrome were significantly higher than in subjects with non-functioning adrenal adenoma and the control group (p < 0.001). Using a cut-off value of 0.18 mu g/dL, the sensitivity and specificity of late-night salivary cortisol for diagnosing subclinical Cushing's syndrome were determined as 82% and 60%, respectively. Using a cut-off value of 137 mu g/day, the sensitivity and specificity of UFC was determined as 18% and 90%, respectively. Conclusions: Because the sensitivity of late-night salivary cortisol for the diagnosis of subclinical Cushing's syndrome is limited, using it as the sole screening test for subclinical Cushing's syndrome may lead to false negative results. However, using it as an adjunct test to other tests may be beneficial in the diagnosis of subclinical Cushing's syndrome.en_US
dc.language.isoengen_US
dc.publisherVia Medicaen_US
dc.identifier.doi10.5603/EP.a2016.0028
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectsubclinical Cushing's syndromeen_US
dc.subjectsalivary cortisolen_US
dc.subjecturinary free cortisolen_US
dc.subjectscreeningen_US
dc.subjectAdrenal Incidentalomaen_US
dc.subjectSerumen_US
dc.subjectHypercortisolismen_US
dc.subjectPerformanceen_US
dc.subjectManagementen_US
dc.subjectSocietyen_US
dc.subjectOverten_US
dc.titleThe diagnostic value of late-night salivary cortisol for diagnosis of subclinical Cushing's syndromeen_US
dc.typearticleen_US
dc.relation.ispartofEndokrynologia Polskaen_US
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalıen_US
dc.authorid0000-0001-5584-4954
dc.authorid0000-0001-8084-848X
dc.identifier.volume67en_US
dc.identifier.issue5en_US
dc.identifier.startpage487en_US
dc.identifier.endpage492en_US
dc.institutionauthorZuhur, Sayid Shafi
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.authorscopusid55753696900
dc.authorscopusid36656843500
dc.authorscopusid56419558300
dc.authorscopusid57191893635
dc.authorscopusid36926020100
dc.authorscopusid35517398400
dc.authorwosidÖztürk, Feyza Yener/AAL-3013-2020
dc.authorwosidZuhur, Sayid/AAC-6839-2020
dc.identifier.wosWOS:000392136100003en_US
dc.identifier.scopus2-s2.0-84994607791en_US
dc.identifier.pmid26884297en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster